Skip to content
Dr. Cannabis

Sharp pine, fresh forest

Alpha-pinene

Common and distinctive. The popular claim that it counteracts THC-induced memory impairment is a hypothesis, not a finding.

Preclinical onlySupported only by laboratory or animal studies, frequently at doses far above what a cannabis product delivers. No human clinical evidence.
Aroma
Sharp pine, fresh forest
Also found in
Pine needles, Rosemary, Basil

Alpha-pinene appears with myrcene in one of the three commercial terpene chemotypes identified across nearly 90,000 samples.

The "pinene protects your memory from THC" claim traces to a hypothesis advanced in the entourage-effect literature. We could not find a human trial testing it.

A 2024 systematic review reported an explicit negative finding: no evidence of neuroprotective or anti-aggregatory effects of alpha-pinene or beta-pinene against beta-amyloid-mediated toxicity. Modest lipid-peroxidation inhibition was the extent of what held up.

What marketing claims

  • • Counteracts THC memory impairment
  • • Bronchodilation
  • • Alertness

What the evidence supports

No human evidence for the memory claim. A 2024 review reported a specific negative neuroprotection finding.

Sources

  1. Smith CJ, Vergara D, Keegan B, Jikomes N. The phytochemical diversity of commercial Cannabis in the United States. PLOS ONE. 2022;17(5):e0267498.(DOI 10.1371/journal.pone.0267498)Accessed 2026-08-15.
  2. André R, Gomes AP, Pereira-Leite C, et al. The Entourage Effect in Cannabis Medicinal Products: A Comprehensive Review. Pharmaceuticals. 2024;17(11):1543.(DOI 10.3390/ph17111543)Accessed 2026-08-15.
  3. Russo EB. The Case for the Entourage Effect and Conventional Breeding of Clinical Cannabis: No "Strain," No Gain. Frontiers in Plant Science. 2019;9:1969.(DOI 10.3389/fpls.2018.01969)Accessed 2026-08-15.